Cancer vaccine treatment that would be the first of its kind passes a key test

Moderna shares shot up after the company announced initial results from a study of an experimental mRNA-based cancer vaccine tailored to individuals.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts